nach oben

Journal of Gastrointestinal Cancer

Erschienen in:

27.08.2021 | Editorial

GADD45aa as a Predictive Biomarker for Aeromonas Infection–Related Liver Cirrhosis

verfasst von: Hamid Sadeghi, Nematollah Gheibi, Saeideh Gholamzadeh Khoei

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Liver cirrhosis is recognized as the 11th leading cause of mortality in the world [1]. Cirrhosis is the last pathological outcome of different chronic liver disorders, and newer research has established that fibrosis is the starter of cirrhosis [2‐4]. Many types of factors are involved in the beginning and development of liver fibrosis and cirrhosis [3]. The most common causes in the liver cirrhosis progression, especially in western countries, include alcoholism, nonalcoholic fatty liver disease, and chronic hepatitis C virus infection [5]. In addition, Gram-negative bacteria such as Escherichia coli, Klebsiella sp., and Aeromonas sp., can be important origins of bacteremia in patients with liver cirrhosis [6, 7]. …

Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–71.CrossRefPubMed

Smith A, Baumgartner K, Bositis C. Cirrhosis: diagnosis and management. Am Fam Physician. 2019;100(12):759–70.PubMed

Zhou W-C, Zhang Q-B, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol: WJG. 2014;20(23):7312.CrossRefPubMedPubMedCentral

Mohagheghi S, Khajehahmadi Z, Nikeghbalian S, Alavian SM, Doosti-Irani A, Khodadadi I, et al. Changes in the distribution of etiologies of cirrhosis among patients referred for liver transplantation over 11 years in Iran. Eur J Gastroenterol Hepatol. 2020;32(7):844–50.CrossRefPubMed

Innes HA, Hutchinson SJ, Barclay S, Cadzow E, Dillon JF, Fraser A, et al. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology. 2013;57(2):451–60.CrossRefPubMed

Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18(3):353–8.CrossRefPubMed

Shizuma T, Tanaka C, Mori H, Fukuyama N. Investigation of bacteremia due to Aeromonas species and comparison with that due to enterobacteria in patients with liver cirrhosis. Gastroenterol Res Pract. 2011;2011.

Brenner DA. Reversibility of liver fibrosis. Gastroenterology & hepatology. 2013;9(11):737.

Yan J, Li S, Li S. The role of the liver in sepsis. Int Rev Immunol. 2014;33(6):498–510.CrossRefPubMedPubMedCentral

10.

Shizuma T, Obata H, Hashimoto E, Shiratori K. Relationship between bacteremia and severity of liver dysfunction in patients with liver cirrhosis. Acta Hepatologica Japonica. 2003;44(12):641–8.CrossRef

11.

Wu C-J, Lee H-C, Chang T-T, Chen C-Y, Lee N-Y, Chang C-M, et al. Aeromonas spontaneous bacterial peritonitis: a highly fatal infectious disease in patients with advanced liver cirrhosis. J Formos Med Assoc. 2009;108(4):293–300.CrossRefPubMed

12.

Mehta AK, Lyon GM. Infectious diseases in end-stage liver disease patients. Critical Care Nursing Clinics. 2010;22(3):291–307.PubMed

13.

Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev. 2010;23(1):35–73.CrossRefPubMedPubMedCentral

14.

Figueras M, Suarez-Franquet A, Chacon M, Soler L, Navarro M, Alejandre C, et al. First record of the rare species Aeromonas culicicola from a drinking water supply. Appl Environ Microbiol. 2005;71(1):538–41.CrossRefPubMedPubMedCentral

15.

Latif Eugenín FL. Aeromonas, un microorganismo ambiental de importancia en salud humana y animal: Universitat Rovira i Virgili. 2015.

16.

Ko W-C, Lee H-C, Chuang Y-C, Liu C-C, Wu J-J. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect. 2000;40(3):267–73.CrossRefPubMed

17.

Cretu A, Sha X, Tront J, Hoffman B, Liebermann DA. Stress sensor Gadd45 genes as therapeutic targets in cancer. Cancer Therapy. 2009;7(A):268.

18.

Balliet AG, Hollander MC, Fornace AJ Jr, Hoffman B, Liebermann DA. Comparative analysis of the genetic structure and chromosomal mapping of the murine Gadd45g/CR6 gene. DNA Cell Biol. 2003;22(7):457–68.CrossRefPubMed

19.

Fang Y, Xu XY, Shen Y, Li J. Molecular cloning and functional analysis of Growth arrest and DNA damage-inducible 45 aa and ab (Gadd45aa and Gadd45 ab) in Ctenopharyngodon idella. Fish Shellfish Immunol. 2018;77:187–93.CrossRefPubMed

Titel: GADD45aa as a Predictive Biomarker for Aeromonas Infection–Related Liver Cirrhosis
verfasst von: Hamid Sadeghi
Nematollah Gheibi
Saeideh Gholamzadeh Khoei
Publikationsdatum: 27.08.2021
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 1/2023
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-021-00694-y

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

GADD45aa as a Predictive Biomarker for Aeromonas Infection–Related Liver Cirrhosis

Excerpt

Neu im Fachgebiet Onkologie

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Onkologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Endoluminal Leiomyoma of the Gastric Antrum: a Report of a Rare Case

A Promising Diagnostic Role of Immunohistochemical Expression of Insulin-Like Growth Factor II mRNA Binding Protein 3 (IMP3) in Pancreatic Lesions Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) Cytology

Short-Term Outcomes After Robotic Versus Open Liver Resection: A Systematic Review and Meta-analysis

The Pro-tumor and Anti-tumor Effects of NLRP3 Inflammasome as a New Therapeutic Option for Colon Cancer: a Meta-analysis of Pre-clinical Studies

Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment

Metabolomic Pathway Activity with Genomic Single-Nucleotide Polymorphisms Associated with Colorectal Cancer Recurrence and 5-Year Overall Survival

Neu im Fachgebiet Onkologie

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Onkologie